Oral e-Poster Presentations - Booth 4: Neuro-Oncology 3 (GBM & malignant gliomas)
Tracks
Mezzanine Floor
| Monday, October 14, 2024 |
| 9:30 AM - 10:10 AM |
Details
Oral e-Posters: 3 minutes presentation duration each
Speakers & Chairs
Prof Hans Clusmann
Director
Uniklinik RWTH Aachen
Chair
Dr Athanasios Chatzisotiriou
Consultant
St Luke Clinic
Chair
Dr Christian Schwalbe
Consultant
Asklepios Klinikum Nord Klinik für Neurochirurgie
Development of Zika Virus E Variants for Pseudotyping Retroviral Vectors Targeting Glioblastoma Cells
Dr Emilia Westarp
Resident
University Hospital Basel
Hydrocephalus in surgically treated glioblastoma patients – To treat or not to treat?
Dr Mariam Awan
Registrar
King's College Hospital
Awake Craniotomy for Diffuse Glioma in Multilingual Patients: Language Outcomes in a match cohort study
Dr Stefano Telera
Md
Irccs Istituto Nazionale Tumori Regina Elena
A real-life study on second surgery for recurrence glioblastoma
Dr FRANCESCA RONCELLI
Phd Student, Neurosurgeon
Vita-Salute San Raffaele University, San Raffaele Hospital
Immune cells subpopulations in peripheral blood in patients with high-grade gliomas
Prof Pietro Familiari
Assistant Professor
Sapienza, University Of Rome
Adult IDH Wild-Type Glioblastoma Ultrastructural Study: a Possible Correlation between Morphological Biomarkers and Ki-67 Index
Mr Timo Schenker
Resident
University Hospital Basel
CAR Macrophages for Brain Tumor Immunotherapy
Dr Pierfrancesco De Domenico
Trainee
IRCCS S. Raffaele Scientific Institute, Milan
Pre-operative Mean Platelet Volume (MPV) is associated with Glioblastoma IDH-wt overall survival, preliminary data from 167 patients
Dr Bilal Bahadır Akbulut
Resident
Ege University Faculty of Medicine
Factors Contributing to Survival of IDH Negative Glioblastomas according to WHO 2021 Classification: Is Resection Extent Relevant?
